Illumina Inc
ILMN
ISIN US4523271090 / Valor 1111080
Illumina Inc
UMushroom community rating:
About company
Illumina Inc is a global company that specializes in applying innovative technologies to the analysis of genetic variation and function. The company focuses on delivering flexible and scalable solutions to meet the needs of its customers in the fields of life science research, translational and consumer genomics, and molecular diagnostics. Illumina's innovative sequencing and array technologies have been instrumental in fueling groundbreaking advancements in these areas, allowing for studies that were previously unimaginable. The company values collaborative interactions, rapid delivery of solutions, and providing the highest level of quality in its products and services.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (07.08.2024):
Revenue Decline
Illumina Inc's revenue for the first quarter of fiscal year 2024 was $1.08 billion, representing a 1% decrease from the $1.09 billion reported in the first quarter of 2023. This decline was consistent on a constant currency basis.
Operating Margins
For Q1 2024, Illumina Inc reported a GAAP operating margin of 11.0% and a non-GAAP operating margin of 20.6%. These figures reflect the company's focus on operational excellence and cost-saving measures.
Earnings Per Share
Illumina Inc's GAAP diluted loss per share for the first quarter of 2024 was ($0.79), a significant drop compared to the GAAP diluted earnings per share of $0.02 in Q1 2023. However, the non-GAAP diluted earnings per share improved to $0.09 from $0.08 in the same period last year.
Cash Flow and Investments
In Q1 2024, Illumina Inc generated $77 million in cash flow from operations, a substantial increase from the $10 million reported in Q1 2023. The company also reported free cash flow of $41 million for the quarter, compared to a negative free cash flow of $(42) million in the prior year period.
Financial Outlook
Illumina Inc reiterated its fiscal year 2024 guidance, expecting Core Illumina revenue to remain approximately flat compared to 2023. The company also anticipates a Core Illumina non-GAAP operating margin of around 20% for the fiscal year.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
20977 M
Market cap (USD)
614,476
Daily traded volume (Shares)
137.18 / 130.11
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
